HOME >> MEDICINE >> NEWS
Older, more rounded and artier applicants make better medical students

Older, artier, and better rounded applicants, with at least one year's work experience would make better medical students and happier doctors, suggests a leading educationalist philosopher in the Journal of Medical Ethics.

Dr Christopher Cowley, of the School of Medicine, Health Policy and Practice at the University of East Anglia, sets out five new admission criteria to select the most suitable candidates for a career in medicine.

He contends that these would ensure that students would not only be technically proficient, but also more capable of understanding both themselves and patients better. This in turn would make them better doctors and help them to enjoy their jobs more, he says.

He proposes:

  • An A level in a humanity or social science to supplement the "stringent science requirement" would allow successful candidates to be better primed for the social science elements in the medical curriculum. And would help shift the pure science focus in "both training and temperament." Any A level that involves written texts and essays would do, he says, and so could include a language, politics, economics, law, or drama.

  • Extra points to be awarded for an A level in English Literature, on the grounds that it improves imagination and empathy, communication skills, and the ability to discuss complex ethical issues.

  • A minimum age requirement of 23, but without the need for a first degree, so as not to disadvantage those from less affluent backgrounds. This would ensure that students were sufficiently mature to know themselves and the world better, so helping them to make a more informed and motivated choice about a medical career, and to understand the patient's point of view better , he says.

  • A year's full time experience in a healthcare or voluntary sector organisation to provide a thorough grounding in the type of environment and ethos in which they
    '"/>


Contact: Emma Dickinson
edickinson@bmj.com
440-207-383-6529
BMJ Specialty Journals
26-Jul-2006


Page: 1 2

Related medicine news :

1. Older, lower income patients least likely to see a specialist for lupus
2. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
3. Waist-to-hip ratio may better predict cardiovascular risk than body mass index
4. Warfarin better than aspirin at stroke prevention in elderly people with atrial fibrillation
5. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
6. Stroke in nonvascular atrial fibrillation -- anti-coagulants better than anti-platelet therapy
7. Holograms make for better vision tests
8. Parents of chronically ill kids are helped by better access to federal and employer leave
9. Diabetes professionals join forces to identify gaps in diabetes care and better self care
10. Exploring better ways to determine when to change the course of treatment
11. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients

Post Your Comments:
(Date:5/23/2013)... FL (PRWEB) May 23, 2013 ... regenerative medicine company focused on the commercialization of ... and regeneration, today announced that the Company and ... million grant, for which AxoGen’s portion is approximately ... administrated by the U.S. Department of Defense (DoD) ...
(Date:5/23/2013)... 2013 Hile Design LLC is pleased ... awarded a Silver Creative Award at the Summit International ... entry was for its “Open Doors” animation promoting Scio ... in the 2013 District 6 ADDY Awards for the ... Creative Award recognizes and celebrates the creative achievements of ...
(Date:5/23/2013)... Utah (PRWEB) May 23, 2013 Registered ... R.D., published an article today on Tatalou.com offering helpful ... vacation. , The article, titled “ How to Stay ... important to carry hand sanitizer, when it’s safe to ... out for seafood, the importance of staying hydrated and ...
(Date:5/23/2013)... OH and Durham, NC (PRWEB) May 23, 2013 ... and commercialization firm that funds and develops innovative ... Deep Brain Innovations, LLC (DBI). DBI will ... optimize deep brain stimulation (DBS) therapy for patients ... is effective in treating Parkinson’s disease and generates ...
(Date:5/23/2013)... Consortium, Ltd., issued the following statement today on ... Reform of chemical safety legislation will succeed only ... Ensuring the safety and appropriate use of chemicals ... Toxic Substances Control Act is a critical opportunity ... transforming toxicity testing "from a system based on ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense 2Health News:AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense 3Health News:How to Stay Healthy While Traveling 2Health News:NDI Launches Deep Brain Innovations, LLC 2Health News:NDI Launches Deep Brain Innovations, LLC 3
(Date:5/22/2013)... PLAINS, N.Y. , May 22, 2013  The ... million to Valor Biotherapeutics, LLC, a joint ... of pre-clinical development, manufacturing, and a Phase I clinical ... the poor outcomes faced by many patients with indolent ... rituximab. Valor,s protein, IGN002, is a ...
(Date:5/22/2013)... CAESAREA, Israel , May 22, 2013 ... presented from the DEFLECT-I study demonstrates that Keystone Heart,s ... volume during TAVR (Transcatheter Aortic Valve Replacement) procedures when ... Advisory Board announces consensus on the importance of preserving ... and need for cerebral protection during cardiovascular procedures to ...
(Date:5/22/2013)... -- For the 3% of the population that suffer from ... anxiety-inducing and disabling.  While more than half of these ... hyperhidrosis is a serious medical condition.  Finally, there is ... Dr. Bruce Katz , ... New York , is leading an ...
Breaking Medicine Technology:The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 3New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 4Is There Finally A Way To Stop Severe Excessive Sweating? 2
Cached News: